Emerald Development Managers
New York, New York, United StatesFounded 1994
Emerald Development Managers is an early-stage venture capital firm that focuses on investing in elite scientific and engineering teams addressing real-world problems. Their investment strategy involves providing capital, industry expertise, and hands-on guidance to companies primarily within the life sciences/biotech/healthtech, enterprise software/cybersecurity, and industrial technology/clean tech/sustainability sectors.
50% of their portfolio is in Cybersecurity. Their most common stage is series-b (50% of deals). Average disclosed round size is $42.0M (across 8 rounds with reported amounts).
Portfolio
8
Fund Size
—
Top Stage
Series B
Last 12 Mo
1
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
8 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Uviquity | Seed | $6.6M | May 2025 |
 Proscia | Unknown | $50M | Mar 2025 |
 Transcend Therapeutics | Series A | $40M | Feb 2023 |
 Evolved By Nature | Series C | $120M | Jun 2022 |
 CybSafe | Series B | $28M | Jun 2022 |
 TrueFort | Series B | $30M | Sep 2021 |
 Cyware | Series B | $30M | Mar 2021 |
 Babson Diagnostics | Series B | $31M | — |
Top Co-Investors
Evolution Equity Partners2 shared
Prism1 shared
Insight Partners1 shared
AFI Capital Partners1 shared
Triangle Peak Partners1 shared
Fusion Fund1 shared
Interwoven Ventures1 shared
Razor's Edge1 shared
Ontario Teachers' Pension Plan1 shared
Senator Investment Group1 shared
Mousse Partners1 shared
CHANEL1 shared
Kraft Group1 shared
Founders Fund1 shared
Alpha Wave Global1 shared
Integrated1 shared
IQ Capital1 shared
Agfunder1 shared
Advent International1 shared
TenEleven Ventures1 shared
Last updated: 16 April 2026